Literature DB >> 2686707

Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.

J M Chen1, G Lee, R B Murphy, R P Carty, P W Brandt-Rauf, E Friedman, M R Pincus.   

Abstract

The GTP-binding p21 protein encoded by the ras-oncogene can be activated to cause malignant transformation of cells by substitution of a single amino acid at critical positions along the polypeptide chain. Substitution of any non-cyclic L-amino acid for Gly 12 in the normal protein results in a transforming protein. This substitution occurs in a hydrophobic sequence (residues 6-15) which is known to be involved in binding the phosphate moities of GTP (and GDP). We find, using conformational energy calculations, that the 6-15 segment of the normal protein (with Gly 12) adopts structures that contain a bend at residues 11 and 12 with the Gly in the D* conformation, not allowed energetically for L-amino acids. Substitution of non-cyclic L-amino acids for Gly 12 results in shifting this bend to residues 12 and 13. We show that many computed structures for the Gly 12-containing phosphate binding loop, segment 9-15, are superimposable on the corresponding segment of the recently determined X-ray crystallographic structure for residues 1-171 of the p21 protein. All such structures contain bends at residues 11 and 12 and most of these contain Gly 12 in the C* or D* conformational state. Other computed conformations for the 9-15 segment were superimposable on the structure of the corresponding 18-23 segment of EFtu, the bacterial chain elongation factor having structural similarities to the p21 protein in the phosphate-binding regions. This segment contains a Val residue where a Gly occurs in the p21 protein. As previously predicted, all of these superimposable conformations contain a bend at positions 12 and 13, not 11 and 12. If these structures that are superimposable on EFtu are introduced into the p21 protein structure, bad contacts occur between the sidechain of the residue (here Val) at position 12 and another phosphate binding loop region around position 61. These bad contacts between the two segments can be removed by changing the conformation of the 61 region in the p21 protein to the corresponding position of the homologous region in EFtu. In this new conformation, a large site becomes available for the binding of phosphate residues. In addition, such phenomena as autophosphorylation of the p21 protein by GTP can be explained with this new model structure for the activated protein which cannot be explained by the structure for the non-activated protein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2686707     DOI: 10.1080/07391102.1989.10506518

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  12 in total

1.  The structure of the carboxyl terminus of the p21 protein. Structural relationship to the nucleotide-binding/transforming regions of the protein.

Authors:  P W Brandt-Rauf; R P Carty; J M Chen; G Lee; S Rackovsky; M R Pincus
Journal:  J Protein Chem       Date:  1990-04

2.  GTPase domains of ras p21 oncogene protein and elongation factor Tu: analysis of three-dimensional structures, sequence families, and functional sites.

Authors:  A Valencia; M Kjeldgaard; E F Pai; C Sander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function.

Authors:  P W Brandt-Rauf; S Rackovsky; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  Prediction of the three-dimensional structure of the rap-1A protein from its homology to the ras-gene-encoded p21 protein.

Authors:  J M Chen; R Grad; R Monaco; M R Pincus
Journal:  J Protein Chem       Date:  1996-01

5.  Structural effects of the binding of GTP to the wild-type and oncogenic forms of the ras-gene-encoded p21 proteins.

Authors:  R Monaco; J M Chen; F K Friedman; P Brandt-Rauf; D Chung; M R Pincus
Journal:  J Protein Chem       Date:  1995-11

6.  Computed three-dimensional structures for the ras-binding domain of the raf-p74 protein complexed with ras-p21 and with its suppressor protein, rap-1A.

Authors:  J M Chen; S Manolatos; P W Brandt-Rauf; R B Murphy; R Monaco; M R Pincus
Journal:  J Protein Chem       Date:  1996-08

7.  Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of the ras-gene-encoded p21 protein with the structure of the normal (non-transforming) wild-type protein.

Authors:  R Monaco; J M Chen; D Chung; P Brandt-Rauf; M R Pincus
Journal:  J Protein Chem       Date:  1995-08

8.  Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.

Authors:  A Liwo; K D Gibson; H A Scheraga; P W Brandt-Rauf; R Monaco; M R Pincus
Journal:  J Protein Chem       Date:  1994-02

9.  Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.

Authors:  Wilbur B Bowne; Josef Michl; Martin H Bluth; Michael E Zenilman; Matthew R Pincus
Journal:  Cancer Ther       Date:  2007

10.  Conformational effects of environmentally induced, cancer-related mutations in the p53 protein.

Authors:  P W Brandt-Rauf; R Monaco; M R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.